MGN The FDA announced another recall of high blood pressure medication due to potential cancer risk due to contamination. SciGen is recalling certain batches of irbesartan. The recalled lot will have “Westminster Pharmaceuticals” and “GSMS Inc.” on the label, according to the FDA. You can view a full recall lot list HERE. MORE: FDA expands valsartan blood pressure medication recall FDA says the recalled lots of these drugs contained N-Nitrosodiethylamine or NDEA, a suspected carcinogen, according to the National Institutes of Health. The FDA said it will continue to test all products containing valsartan and similar drugs for the presence of impurities. For more from the FDA visit their website.